michael atkins, md, on mrcc patients whose cancer returns and were previously treated with i-o
Published 4 years ago • 34 plays • Length 0:55
Download video MP4
Download video MP3
Similar videos
-
0:40
michael atkins, md, considers how to treat mrcc after combination i-o in the 1st line setting
-
1:15
michael b. atkins, md, on selecting i-o and tki combinations for the treatment of 1st line rcc
-
1:20
michael atkins, md, offers opinion on io-tki combinations in renal cell cancer
-
0:51
michael atkins, md, shares exciting potential of current late-stage clinical studies in rcc patients
-
0:58
michael atkins, md, regarding the keynote 426 phase iii trial in metastatic renal cell carcinoma
-
0:41
michael atkins, md, on appropriate patient types to receive a tki in the treatment of 1st line rcc
-
1:08
michael b. atkins, md, on the role of imdc classification in treatment decision-making
-
0:44
michael atkins, md, on follow up investigation of checkmate 025 in renal cell carcinoma patients
-
1:37
michael b. atkins, md, comments on clinical trials investigating the use of i-o and tkis in rcc
-
0:52
michael b. atkins, md, considers preferred agents in the treatment of rcc in the 2nd line
-
2:23
dr. michael atkins on immunotherapy or targeted therapy as first treatment for advanced melanoma
-
2:53
michael b. atkins, md, regarding the long-term follow up of checkmate-004 in metastatic melanoma
-
0:26
michael atkins, md, regarding single agent tkis in the 1st line setting
-
2:01
michael atkins, md, discusses checkmate-214 investigating nivolumab ipilimumab in rcc patients
-
1:19
courtney dinardo, md, regarding the evolution of treatment in acute myeloid leukemia
-
11:23
new targets, new pathways michael b. atkins, m.d.
-
0:57
dr. choti discusses immunotherapy in pancreatic cancer
-
1:01:05
april 30, 2019 - robert negrin, md
-
12:16
single cell immunogenomic profiling... - yi-ping "irene" shih (d2p24)
Clip.africa.com - Privacy-policy